© iStock

May 2020 − News

 

 

Despite ongoing ethical discussions, the genome editing system CRISPR has long been accepted practice in international research. A team of scientists from the Broad Institute in Cambridge, USA, has now developed the method even further: in the case of prime editing, the DNA is no longer cut, but its components are precisely exchanged, deleted or altered – a method touted to carry a lower risk. Prime editing could one day enable the correction of 89 percent of all heritable human diseases.

Contact

Imprint

Legal Notice

Trademarks & Patents

External Trademarks & Disclaimer

 

 

© 2019 Eppendorf AG. All rights reserved.